New Collaboration Offers Hope Of Parkinson’s Treatments

Eisai, a Japanese pharmaceutical company, and Wren Therapeutics, a spin-off company from the University of Cambridge in the UK and Lund University in Sweden, have announced an exclusive research collaboration agreement. The news that the two firms will be working together to further drug discovery for a range of conditions that involve synucleinopathies could bring hope to those suffering from …